Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 549

1.

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion.

Ascione A, Arenaccio C, Mallano A, Flego M, Gellini M, Andreotti M, Fenwick C, Pantaleo G, Vella S, Federico M.

BMC Biotechnol. 2019 Oct 17;19(1):67. doi: 10.1186/s12896-019-0559-x.

PMID:
31623599
2.

Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.

Federico M, Hernandez-Socorro CR, Ribeiro I, Martin JG, Oramas MDR, Saez-Bravo ML, Jimenez PCL.

Radiat Oncol. 2019 Oct 4;14(1):173. doi: 10.1186/s13014-019-1352-7.

3.

Management of endometrial cancer in patients aged 80 years and older: Identifying patients who may benefit from a curative treatment.

Benito V, Lubrano A, Andújar M, Mori M, Federico M.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep 17;242:36-42. doi: 10.1016/j.ejogrb.2019.09.007. [Epub ahead of print]

PMID:
31550627
4.

Draft Genome Sequences of Mycoplasma mycoides subsp. mycoides Strains APF9 and AP108, Isolated in Nigeria in 2014 to 2016.

Di Federico M, Orsini M, Ancora M, Marcacci M, Di Domenico M, Krasteva I, Zilli K, Musa JA, Francis MI, Sacchini F, Scacchia M, Cammà C.

Microbiol Resour Announc. 2019 Sep 19;8(38). pii: e00783-19. doi: 10.1128/MRA.00783-19.

5.

Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.

Lansigan F, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM.

Acta Haematol. 2019 Jul 17:1-11. doi: 10.1159/000500666. [Epub ahead of print]

PMID:
31315113
6.

Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs.

Chiozzini C, Olivetta E, Sanchez M, Arenaccio C, Ferrantelli F, Leone P, Federico M.

J Mol Med (Berl). 2019 Aug;97(8):1139-1153. doi: 10.1007/s00109-019-01797-7. Epub 2019 Jun 3.

PMID:
31161312
7.

Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone.

Cotter JM, Tyler A, Reese J, Ziniel S, Federico MJ, Anderson Iii WC, Kupfer O, Szefler SJ, Kerby G, Hoch HE.

J Asthma. 2019 Jun 12:1-7. doi: 10.1080/02770903.2019.1622713. [Epub ahead of print]

PMID:
31113252
8.

High-risk asthma: Never give up.

Federico MJ, Szefler SJ.

Ann Allergy Asthma Immunol. 2019 May;122(5):441-442. doi: 10.1016/j.anai.2019.03.013. No abstract available.

PMID:
31054649
9.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project.

Bellei M, Federico M.

Haematologica. 2019 Apr;104(4):e178. doi: 10.3324/haematol.2019.218305. No abstract available.

10.

Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.

Stuver RN, Khan N, Schwartz M, Acosta M, Federico M, Gisselbrecht C, Horwitz SM, Lansigan F, Pinter-Brown LC, Pro B, Shustov AR, Foss FM, Jain S.

Am J Hematol. 2019 Jun;94(6):641-649. doi: 10.1002/ajh.25463. Epub 2019 Apr 9.

PMID:
30896890
11.

Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.

Carbajosa S, Pansa MF, Paviolo NS, Castellaro AM, Andino DL, Nigra AD, García IA, Racca AC, Rodriguez-Berdini L, Angiolini V, Guantay L, Villafañez F, Federico MB, Rodríguez-Baili MC, Caputto BL, Drewes G, Madauss KP, Gloger I, Fernandez E, Gil GA, Bocco JL, Gottifredi V, Soria G.

Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19.

PMID:
30890549
12.

Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO.

Spatola C, Privitera G, Milazzotto R, Tocco A, Acquaviva G, Marletta F, Marino L, Di Grazia A, Salvo R, Cartia G, Platania A, Molino L, Santacaterina A, Mattace Raso M, Frosina P, Ianni R, Bono M, Liardo L, Bonanno S, La Paglia L, Federico M, Fazio I, Mortellaro G, Ferrera G, Tripoli A, Evangelista G, Daidone A, Biti G, Badalamenti M, Ognibene L, Cacciola A, Parisi S, Pergolizzi S.

Radiol Med. 2019 Jul;124(7):671-681. doi: 10.1007/s11547-019-01007-x. Epub 2019 Feb 26.

PMID:
30806918
13.

Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).

Rusconi C, Anastasia A, Chiarenza A, Marcheselli L, Cavallo F, Rattotti S, Botto B, Ferrari A, Nassi L, Pagani C, Meli E, Arcaini L, Federico M, Rossi G; Fondazione Italiana Linfomi (FIL).

Br J Haematol. 2019 May;185(4):713-717. doi: 10.1111/bjh.15816. Epub 2019 Feb 21.

PMID:
30793297
14.

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.

Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR; COMPLETE Investigators.

Cancer. 2019 May 1;125(9):1507-1517. doi: 10.1002/cncr.31861. Epub 2019 Jan 29. Erratum in: Cancer. 2019 Nov 1;125(21):3893.

PMID:
30694529
15.

Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes.

Di Bonito P, Accardi L, Galati L, Ferrantelli F, Federico M.

Cancers (Basel). 2019 Jan 24;11(2). pii: E138. doi: 10.3390/cancers11020138. Review.

16.

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C.

Br J Haematol. 2018 Dec;183(5):755-765. doi: 10.1111/bjh.15641. Epub 2018 Nov 8.

PMID:
30407629
17.

DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.

Ferrantelli F, Manfredi F, Chiozzini C, Anticoli S, Olivetta E, Arenaccio C, Federico M.

Mol Biotechnol. 2018 Nov;60(11):773-782. doi: 10.1007/s12033-018-0114-3.

PMID:
30167966
18.

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications.

Toss A, Piacentini F, Cortesi L, Artuso L, Bernardis I, Parenti S, Tenedini E, Ficarra G, Maiorana A, Iannone A, Omarini C, Moscetti L, Cristofanilli M, Federico M, Tagliafico E.

Oncotarget. 2018 Aug 3;9(60):31606-31619. doi: 10.18632/oncotarget.25810. eCollection 2018 Aug 3.

20.

Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study.

Federico MP, Furtado GH.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2153-2158. doi: 10.1007/s10096-018-3352-1. Epub 2018 Aug 15.

PMID:
30112695
21.
22.

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.

Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium.

Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4.

PMID:
30078408
23.

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eichenauer DA, Aleman BMP, André M, Federico M, Hutchings M, Illidge T, Engert A, Ladetto M; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv19-iv29. doi: 10.1093/annonc/mdy080. No abstract available.

PMID:
29796651
24.

Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications.

Arenaccio C, Chiozzini C, Ferrantelli F, Leone P, Olivetta E, Federico M.

Curr Drug Targets. 2019;20(1):87-95. doi: 10.2174/1389450119666180521100409.

PMID:
29779478
25.

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network.

Br J Haematol. 2018 Jun;181(6):760-769. doi: 10.1111/bjh.15258. Epub 2018 Apr 19.

26.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.

Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A, Advani RH, Pesce EA, Ko YH, Martinez V, Montoto S, Chiattone C, Moskowitz A, Spina M, Biasoli I, Manni M, Federico M; International T-cell Project Network.

Haematologica. 2018 Jul;103(7):1191-1197. doi: 10.3324/haematol.2017.186577. Epub 2018 Mar 29.

27.

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.

Cottereau AS, Versari A, Luminari S, Dupuis J, Chartier L, Casasnovas RO, Berriolo-Riedinger A, Menga M, Haioun C, Tilly H, Tarantino V, Federico M, Salles G, Trotman J, Meignan M.

Blood. 2018 May 31;131(22):2449-2453. doi: 10.1182/blood-2017-11-816298. Epub 2018 Mar 20.

PMID:
29559480
28.

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Cottereau AS, Versari A, Loft A, Casasnovas O, Bellei M, Ricci R, Bardet S, Castagnoli A, Brice P, Raemaekers J, Deau B, Fortpied C, Raveloarivahy T, Van Zele E, Chartier L, Vander Borght T, Federico M, Hutchings M, Ricardi U, Andre M, Meignan M.

Blood. 2018 Mar 29;131(13):1456-1463. doi: 10.1182/blood-2017-07-795476. Epub 2018 Feb 1.

PMID:
29437590
29.

Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.

Anticoli S, Aricò E, Arenaccio C, Manfredi F, Chiozzini C, Olivetta E, Ferrantelli F, Lattanzi L, D'Urso MT, Proietti E, Federico M.

J Mol Med (Berl). 2018 Feb;96(2):211-221. doi: 10.1007/s00109-017-1617-2. Epub 2017 Dec 27.

PMID:
29282521
30.

An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.

Anticoli S, Manfredi F, Chiozzini C, Arenaccio C, Olivetta E, Ferrantelli F, Capocefalo A, Falcone E, Ruggieri A, Federico M.

Biotechnol J. 2018 Apr;13(4):e1700443. doi: 10.1002/biot.201700443. Epub 2018 Mar 24.

PMID:
29274250
31.

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

Luminari S, Ferrari A, Manni M, Dondi A, Chiarenza A, Merli F, Rusconi C, Tarantino V, Tucci A, Vitolo U, Kovalchuk S, Angelucci E, Pulsoni A, Arcaini L, Angrilli F, Gaidano G, Stelitano C, Bertoldero G, Cascavilla N, Salvi F, Ferreri AJM, Vallisa D, Marcheselli L, Federico M.

J Clin Oncol. 2018 Mar 1;36(7):689-696. doi: 10.1200/JCO.2017.74.1652. Epub 2017 Nov 2.

PMID:
29095677
32.

Transformed follicular lymphoma.

Fischer T, Zing NPC, Chiattone CS, Federico M, Luminari S.

Ann Hematol. 2018 Jan;97(1):17-29. doi: 10.1007/s00277-017-3151-2. Epub 2017 Oct 18. Review.

PMID:
29043381
33.

Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.

Federico MB, Campodónico P, Paviolo NS, Gottifredi V.

Mutat Res. 2018 Mar;808:83-92. doi: 10.1016/j.mrfmmm.2017.09.004. Epub 2017 Sep 14. Review.

PMID:
29031493
34.

ACCIDENTAL DUPLICATION: Beyond interstrand crosslinks repair: Contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.

Federico MB, Campodónico P, Paviolo NS, Gottifredi V.

Mutat Res. 2017 Sep 25. pii: S0027-5107(17)30167-7. doi: 10.1016/j.mrfmmm.2017.09.006. [Epub ahead of print]

PMID:
28966006
35.

The Multifaceted Functions of Exosomes in Health and Disease: An Overview.

Arenaccio C, Federico M.

Adv Exp Med Biol. 2017;998:3-19. doi: 10.1007/978-981-10-4397-0_1. Review.

PMID:
28936729
36.

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.

Eichenauer DA, Becker I, Monsef I, Chadwick N, de Sanctis V, Federico M, Fortpied C, Gianni AM, Henry-Amar M, Hoskin P, Johnson P, Luminari S, Bellei M, Pulsoni A, Sydes MR, Valagussa P, Viviani S, Engert A, Franklin J.

Haematologica. 2017 Oct;102(10):1748-1757. doi: 10.3324/haematol.2017.167478. Epub 2017 Sep 14. Review.

37.

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.

Cortesi L, De Matteis E, Toss A, Marchi I, Medici V, Contu G, Xholli A, Grandi G, Cagnacci A, Federico M.

Oncology. 2017;93(6):377-386. doi: 10.1159/000479155. Epub 2017 Aug 26.

PMID:
28848147
38.

Iatrogenic injury of the intrathoracic oesophagus with bougie during sleeve gastrectomy.

Signorini FJ, Verónica G, Marcos M, German V, Federico M.

J Minim Access Surg. 2018 Jan-Mar;14(1):79-82. doi: 10.4103/jmas.JMAS_21_17.

39.

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.

Di Bonito P, Chiozzini C, Arenaccio C, Anticoli S, Manfredi F, Olivetta E, Ferrantelli F, Falcone E, Ruggieri A, Federico M.

Int J Nanomedicine. 2017 Jun 23;12:4579-4591. doi: 10.2147/IJN.S131309. eCollection 2017.

40.

Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al.

André MPE, Federico M, Fortpied C, Girinsky T, Meignan M, Raemaekers J.

J Clin Oncol. 2017 Aug 20;35(24):2853-2854. doi: 10.1200/JCO.2017.74.0068. Epub 2017 Jul 6. No abstract available.

PMID:
28682682
41.

Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir.

Chiozzini C, Arenaccio C, Olivetta E, Anticoli S, Manfredi F, Ferrantelli F, d'Ettorre G, Schietroma I, Andreotti M, Federico M.

Arch Virol. 2017 Sep;162(9):2565-2577. doi: 10.1007/s00705-017-3391-4. Epub 2017 May 4.

PMID:
28474225
42.

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE.

Ann Oncol. 2017 Jul 1;28(7):1436-1447. doi: 10.1093/annonc/mdx097. Review.

43.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J.

J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.

PMID:
28291393
44.

Normokalemic Thyrotoxic Periodic Paralysis with Acute Resolution in the Emergency Department.

Gragg JI, Federico M, Mellick LB.

Clin Pract Cases Emerg Med. 2017 Mar 15;1(2):129-131. doi: 10.5811/cpcem.2017.1.33211. eCollection 2017 May.

45.

Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations: A Randomized Controlled Trial.

Navanandan N, Federico M, Mistry RD.

J Pediatr. 2017 Jun;185:149-154.e2. doi: 10.1016/j.jpeds.2017.02.032. Epub 2017 Mar 8.

PMID:
28284473
46.

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.

Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM.

Clin Lymphoma Myeloma Leuk. 2017 Apr;17(4):193-200. doi: 10.1016/j.clml.2016.10.001. Epub 2017 Jan 10.

PMID:
28209473
47.

Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?

Benito V, Carballo S, Silva P, Esparza M, Arencibia O, Federico M, Andújar M, Mori M, Medina N, Lubrano A.

J Minim Invasive Gynecol. 2017 May - Jun;24(4):609-616. doi: 10.1016/j.jmig.2017.01.016. Epub 2017 Feb 1.

PMID:
28161495
48.

Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.

Ricciuti G, Finolezzi E, Luciani S, Ranucci E, Federico M, Di Nicola M, Zecca IAL, Angrilli F.

Hematol Oncol. 2018 Feb;36(1):44-48. doi: 10.1002/hon.2386. Epub 2017 Feb 3.

PMID:
28156055
49.

Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.

Federico M, Portiansky EL, Sommese L, Alvarado FJ, Blanco PG, Zanuzzi CN, Dedman J, Kaetzel M, Wehrens XHT, Mattiazzi A, Palomeque J.

J Physiol. 2017 Jun 15;595(12):4089-4108. doi: 10.1113/JP273714. Epub 2017 Mar 2.

50.

Reply to H.J.A. Adams et al and E. Laffon et al.

Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas RO, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J.

J Clin Oncol. 2017 Mar 10;35(8):920-923. doi: 10.1200/JCO.2016.71.0459. Epub 2016 Dec 28. No abstract available.

PMID:
28029310

Supplemental Content

Loading ...
Support Center